1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
35.46%
Positive revenue growth while FSLR is negative. John Neff might see a notable competitive edge here.
-171.55%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-922.43%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-930.10%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-948.31%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-946.15%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-943.59%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.00%
Share reduction more than 1.5x FSLR's 0.02%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.07%
Slight or no buyback while FSLR is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
279.96%
Positive OCF growth while FSLR is negative. John Neff would see this as a clear operational advantage vs. the competitor.
19.65%
Positive FCF growth while FSLR is negative. John Neff would see a strong competitive edge in net cash generation.
58.55%
10Y revenue/share CAGR above 1.5x FSLR's 20.81%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-17.44%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-46.77%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
23.68%
10Y OCF/share CAGR under 50% of FSLR's 211.28%. Michael Burry would worry about a persistent underperformance in cash creation.
-71.13%
Negative 5Y OCF/share CAGR while FSLR is at 10.46%. Joel Greenblatt would question the firm’s operational model or cost structure.
-63.14%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-6403.77%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-234.35%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-497.53%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-91.06%
Negative equity/share CAGR over 10 years while FSLR stands at 232.33%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-87.75%
Negative 5Y equity/share growth while FSLR is at 17.90%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-91.23%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.19%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-13.57%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-15.77%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-74.09%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-24.22%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-4.20%
Our R&D shrinks while FSLR invests at 13.11%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
6.03%
SG&A growth well above FSLR's 8.81%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.